Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PROSTATE SPECIFIC ANTIGEN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1737 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Shao, ZM; Nguyen, M
      Nipple aspiration in diagnosis of breast cancer

      SEMINARS IN SURGICAL ONCOLOGY
    2. Matzkin, H
      Freezing the prostate

      ISRAEL MEDICAL ASSOCIATION JOURNAL
    3. Bichsel, VE; Liotta, LA; Petricoin, EF
      Cancer proteomics: From biomarker discovery to signal pathway profiling

      CANCER JOURNAL
    4. Mannello, F; Gazzanelli, G
      Prostate-specific antigen (PSA/hK3): a further player in the field of breast cancer diagnostics?

      BREAST CANCER RESEARCH
    5. Wymenga, LFA; Boomsma, JHB; Groenier, K; Piers, DA; Mensink, HJA
      Routine bone scans in patients with prostate cancer related to serum prostate-specific antigen and alkaline phosphatase

      BJU INTERNATIONAL
    6. Wymenga, LFA; Gronier, K; Schuurman, J; Boomsma, JHB; Elferink, RO; Mensink, HJA
      Pretreatment levels of urinary deoxypyridinoline as a potential marker in patients with prostate cancer with or without bone metastasis

      BJU INTERNATIONAL
    7. Wu, TT; Huang, JK
      Annual changes in the clinical features of prostatic adenocarcinoma in Taiwan

      BJU INTERNATIONAL
    8. Iorgulescu, DG; Kiroff, GK
      Minimal residual marrow disease: Detection and significance of isolated tumour cells in bone marrow

      ANZ journal of surgery
    9. Gelmini, S; Tricarico, C; Vona, G; Livi, L; Della Melina, A; Semi, S; Cellai, E; Magrini, S; Villari, D; Carini, M; Serio, M; Forti, G; Pazzagli, M; Orlando, C
      Real-time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) for the measurement of prostate-specific antigen mRNA in the peripheral blood of patients with prostate carcinoma using the TaqMan (TM) detection system

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    10. Clements, J; Hooper, J; Dong, Y; Harvey, T
      The expanded human kallikrein (KLK) gene family: Genomic organisation, tissue-specific expression and potential functions

      BIOLOGICAL CHEMISTRY
    11. Walker, B; Lynas, JF
      Strategies for the inhibition of serine proteases

      CELLULAR AND MOLECULAR LIFE SCIENCES
    12. Bockmann, B; Grill, HJ; Giesing, M
      Molecular characterization of minimal residual cancer cells in patients with solid tumors

      BIOMOLECULAR ENGINEERING
    13. Sumi, S; Arai, K; Yoshida, K
      Separation methods applicable to prostate cancer diagnosis and monitoring therapy

      JOURNAL OF CHROMATOGRAPHY B
    14. Chadha, KC; Kawinski, E; Sulkowski, E
      Thiophilic interaction chromatography of prostate-specific antigen

      JOURNAL OF CHROMATOGRAPHY B
    15. Ohkubo, S; Miyadera, K; Sugimoto, Y; Matsuo, K; Wierzba, K; Yamada, Y
      Substrate phage as a tool to identify novel substrate sequences of proteases

      COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
    16. Zumkeller, W
      IGFs and IGFBPs: surrogate markers for diagnosis and surveillance of tumour growth?

      JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY
    17. Lujan, M; Paez, A; Llanes, L; Miravalles, E; Berenguer, A
      Prostate specific antigen density. Is there a role for this parameter whenscreening for prostate cancer?

      PROSTATE CANCER AND PROSTATIC DISEASES
    18. Sriprasad, S; Dew, TK; Muir, GH; Thompson, PM; Mulvin, D; Choi, WH; Dickinson, IK; Sherwood, RA
      Validity of PSA, free/total PSA ratio and complexed/total PSA ratio measurements in men with acute urinary retention

      PROSTATE CANCER AND PROSTATIC DISEASES
    19. Eri, LM; Tveter, KJ
      Effects of bicalutamide and leuprolide on prostate-specific antigen (PSA),acid phosphatase (ACP) and prostatic acid phosphatase (PAP) in men with benign prostatic hyperplasia (BPH)

      PROSTATE CANCER AND PROSTATIC DISEASES
    20. Mifsud, A; Choon, AT; Fang, D; Yong, EL
      Prostate-specific antigen, testosterone, sex-hormone binding globulin and androgen receptor CAG repeat polymorphisms in subfertile and normal men

      MOLECULAR HUMAN REPRODUCTION
    21. Valdes, G; Chacon, C; Corthorn, J; Figueroa, CD; Germain, AM
      Tissue kallikrein in human placenta in early and late gestation

      ENDOCRINE
    22. Holmes, EH
      PSMA specific antibodies and their diagnostic and therapeutic use

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    23. Damen, EWP; de Groot, FMH; Scheeren, HW
      Novel anthracycline prodrugs

      EXPERT OPINION ON THERAPEUTIC PATENTS
    24. Savelli, G; Maffioli, L; Maccauro, M; De Deckere, E; Bombardieri, E
      Bone scintigraphy and the added value of SPECT (single photon emission tomography) in detecting skeletal lesions

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    25. Zusman, I; Ben-Hur, H
      Serological markers for detection of cancer (Review)

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    26. Kirn, D; Martuza, RL; Zwiebel, J
      Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

      NATURE MEDICINE
    27. Eid, JE; Brunner, A; Cummings, KB; Weiss, RE; Goodin, S; Aisner, J; Todd, M; DiPaola, RS
      Effect of P-30 protein and tamoxifen on transforming growth factor-beta 1 in patients with rising prostate specific antigen

      UROLOGIC ONCOLOGY
    28. Wieder, J; Freedland, SJ; Pantuck, AJ; Zisman, A; Belldegrun, AS
      Update on gene and immune based therapy for urologic malignancy

      UROLOGIC ONCOLOGY
    29. Grossman, HB
      PSA: between a ROC and a hard place

      UROLOGIC ONCOLOGY
    30. Dong, Y; Kaushal, A; Bui, L; Chu, S; Fuller, PJ; Nicklin, J; Samaratunga, H; Clements, JA
      Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas

      CLINICAL CANCER RESEARCH
    31. Luo, LY; Katsaros, D; Scorilas, A; Fracchioli, S; Piccinno, R; de la Longrais, IA; Howarth, DJC; Diamandis, EP
      Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma

      CLINICAL CANCER RESEARCH
    32. Magklara, A; Scorilas, A; Katsaros, D; Massobrio, M; Yousef, GM; Fracchioli, S; Danese, G; Diamandis, EP
      The human KLK8 (neuropsin/ovasin) gene: Identification of two novel splicevariants and its prognostic value in ovarian cancer

      CLINICAL CANCER RESEARCH
    33. Schlegel, PN
      What's new in urology

      JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
    34. Baron, AT; Lafkyk, JM; Suman, VJ; Hillman, DW; Buenafe, MC; Boardman, CH; Podratz, KC; Perez, EA; Maihle, NJ
      A preliminary study of serum concentrations of soluble epidermal growth factor receptor (sErbB1), gonadotropins, and steroid hormones in healthy men and women

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    35. Korkmaz, KS; Korkmaz, CG; Pretlow, TG; Saatcioglu, F
      Distinctly different gene structure of KLK4/KLK-L1/prostase/ARM1 compared with other members of the Kallikrein family: Intracellular localization, alternative cDNA forms, and regulation by multiple hormones

      DNA AND CELL BIOLOGY
    36. Varghese, S; Newsome, JT; Rabkin, SD; McGeagh, K; Mahoney, D; Nielsen, P; Todo, T; Martuza, RL
      Preclinical safety evaluation of G207, a replication-competent herpes simplex virus type 1, inoculated intraprostatically in mice and nonhuman primates

      HUMAN GENE THERAPY
    37. McLaughlin, PMJ; Kroesen, BJ; Harmsen, MC; de Leij, LFMH
      Cancer immunotherapy: insights from transgenic animal models

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    38. Duffy, MJ
      Clinical uses of tumor markers: A critical review

      CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES
    39. Kanoh, Y; Ohtani, N; Ohara, T; Mashiko, T; Ohtani, S; Egawa, S; Baba, S; Ohtani, H
      Progression of prostate cancer: Diagnostic and prognostic utility of prostate-specific antigen, alpha(2)-macroglobulin, and their complexes

      ONCOLOGY REPORTS
    40. Shao, ZM; Liu, YH; Nguyen, M
      The role of the breast ductal system in the diagnosis of cancer (Review)

      ONCOLOGY REPORTS
    41. Filella, X; Molina, R; Alcover, J; Coca, F; Zarco, MA; Ballesta, AM
      Influence of AFP, CEA and PSA on the in vitro production of cytokines

      TUMOR BIOLOGY
    42. George, B; Cote, RJ; Datar, RH
      Nucleic acids in disease prognosis

      NATIONAL MEDICAL JOURNAL OF INDIA
    43. Huang, XF; Luu-The, V
      Modulation of the androgenic response by recombinant human 11-cis retinol dehydrogenase

      JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
    44. Huang, PS; Oliff, A
      Drug-targeting strategies in cancer therapy

      CURRENT OPINION IN GENETICS & DEVELOPMENT
    45. Upadhyay, L; Tripathi, K; Kulkarni, KS
      A study of Prostane in the treatment of benign prostatic hyperplasia

      PHYTOTHERAPY RESEARCH
    46. Kim, JJ; Yang, JS; Nottingham, LK; Tang, WX; Dang, K; Manson, KH; Wyand, MS; Wilson, DM; Weiner, DB
      Induction of immune responses and safety profiles in rhesus macaques immunized with a DNA vaccine expressing human prostate specific antigen

      ONCOGENE
    47. Kurtulmus, Y; Tanyalcin, T; Bozkaya, G; Gunduz, O; Cerci, O; Kutay, FZ; Ersoz, B
      Standardized method comparison for ACS : 180 plus and Immulite sensitive PSA (sPSA) measurement methods

      ACCREDITATION AND QUALITY ASSURANCE
    48. de Groot, FMH; Damen, EWP; Scheeren, HW
      Anticancer prodrugs for application in monotherapy: Targeting hypoxia, tumor-associated enzymes, and receptors

      CURRENT MEDICINAL CHEMISTRY
    49. Liao, CH; Liu, SP; Pu, YS; Huang, CY; Yu, HJ; Chen, J
      Effect of percent free prostate-specific antigen measurement on improving the specificity of serum prostate-specific antigen testing in Taiwanese patients

      JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
    50. Janciauskiene, S
      Conformational properties of serine proteinase inhibitors (serpins) confermultiple pathophysiological roles

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
    51. Oudard, S; Caty, A; Humblet, Y; Beauduin, M; Suc, E; Piccart, M; Rolland, F; Fumoleau, P; Bugat, R; Houyau, P; Monnier, A; Sun, X; Montcuquet, P; Breza, J; Novak, J; Gil, T; Chopin, D
      Phase II study of vinorelbine in patients with androgen-independent prostate cancer

      ANNALS OF ONCOLOGY
    52. Berruti, A; Dogliotti, L; Mosca, A; Gorzegno, G; Bollito, E; Mari, M; Tarabuzzi, R; Poggio, M; Torta, M; Fontana, D; Angeli, A
      Potential clinical value of circulating chromogranin A in patients with prostate carcinoma

      ANNALS OF ONCOLOGY
    53. Okegawa, T; Noda, H; Ohta, M; Kato, M; Nutahara, K; Higashihara, E
      Use of various combinations of free, complexed and total prostate-specificantigen levels as predictors of the pathologic stage of prostate cancer

      INTERNATIONAL JOURNAL OF UROLOGY
    54. Minei, S; Hachiya, T; Ishida, H; Okada, K
      Adenoid cystic carcinoma of the prostate: A case report with immunohistochemical and in situ hybridization staining for prostate-specific antigen

      INTERNATIONAL JOURNAL OF UROLOGY
    55. Yamamoto, S; Ito, T; Akiyama, A; Aizawa, T; Miki, M; Tachibana, M
      M1 prostate cancer with a serum level of prostate-specific antigen less than 10 ng/mL

      INTERNATIONAL JOURNAL OF UROLOGY
    56. Egawa, S; Suyama, K; Arai, Y; Tsukayama, C; Matsumoto, K; Kuwao, S; Baba, S
      Treatment outcome by risk group after radical prostatectomy in Japanese men

      INTERNATIONAL JOURNAL OF UROLOGY
    57. Onozawa, M; Fukuda, K; Watanabe, M; Ohtani, M; Akaza, H; Sugimura, T; Wakabayashi, K
      Detection and cloning of a protein recognized by anti-human prostate-specific antigen (PSA) antibody in the rat ventral prostate

      JAPANESE JOURNAL OF CANCER RESEARCH
    58. Soletormos, G
      Serological tumor markers for monitoring breast cancer

      DANISH MEDICAL BULLETIN
    59. Godley, PA; Rathore, SS; Kshirsagar, AV; Amamoo, MA; Schell, MJ; Freeman, J; Harris, RP
      Retrospective classification of prostate-specific antigen tests: Differentiating screening from diagnostic clinical encounters

      JOURNAL OF CLINICAL EPIDEMIOLOGY
    60. Concato, J; Peduzzi, P; Kamina, A; Horwitz, RI
      A nested case-control study of the effectiveness of screening for prostatecancer: research design

      JOURNAL OF CLINICAL EPIDEMIOLOGY
    61. Heeringa, SG; Alcser, KH; Doerr, K; Strawderman, M; Cooney, K; Medbery, B; Schottenfeld, D
      Potential selection bias in a community-based study of PSA levels in African-American men

      JOURNAL OF CLINICAL EPIDEMIOLOGY
    62. Reutens, AT; Fu, MF; Wang, CG; Albanese, C; McPhaul, MJ; Sun, ZJ; Balk, SP; Janne, OA; Palvimo, JJ; Pestell, RG
      Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent manner

      MOLECULAR ENDOCRINOLOGY
    63. Sharma, M; Sun, Z
      5 ' TG3 ' interacting factor interacts with Sin3A and represses AR-mediated transcription

      MOLECULAR ENDOCRINOLOGY
    64. Yousef, GM; Diamandis, M; Jung, K; Diamandis, EP
      Molecular cloning of a novel human acid phosphatase gene (ACPT) that is highly expressed in the testis

      GENOMICS
    65. Malatesta, M; Mannello, F; Sebastiani, M; Gazzanelli, G
      Differential distribution of soluble and complexed forms of prostate-specific antigen in cyst fluids of women with gross cystic breast disease

      JOURNAL OF CLINICAL LABORATORY ANALYSIS
    66. Dunn, AS; Shridharani, KV; Lou, W; Bernstein, J; Horowitz, CR
      Physician-patient discussions of controversial cancer screening tests

      AMERICAN JOURNAL OF PREVENTIVE MEDICINE
    67. Patel, D; Frelinger, J; Goudsmit, J; Kim, B
      In vitro assay for site-specific proteases using bead-attached GFP substrate

      BIOTECHNIQUES
    68. Ylikoski, A; Karp, M; Lilja, H; Lovgren, T
      Dual-label detection of amplified products in quantitative RT-PCR assay using lanthanide-labeled probes

      BIOTECHNIQUES
    69. Swanson, MG; Vigneron, DB; Tran, TKC; Kurhanewicz, J
      Magnetic resonance imaging and spectroscopic imaging of prostate cancer

      CANCER INVESTIGATION
    70. Fava, TA; Desnoyers, R; Schulz, S; Park, J; Weinberg, D; Mitchell, E; Waldman, SA
      Ectopic expression of guanylyl cyclase C in CD34(+) progenitor cells in peripheral blood

      JOURNAL OF CLINICAL ONCOLOGY
    71. Ciatto, S; Bonardi, R; Lombardi, C; Cappelli, G; Castagnoli, A; D'Agata, A; Zappa, M; Gervasi, G
      Predicting prostate biopsy outcome by findings at digital rectal examination, transrectal ultrasonography, PSA, PSA density and free-to-total PSA ratio in a population-based screening setting

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    72. Thomas, CMG; Sweep, CGJ
      Serum tumor markers: past, state of the art, and future

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    73. Kuroi, K; Toi, M
      Circulating angiogenesis regulators in cancer patients

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    74. Sato, I; Yoshiike, M; Yamasaki, T; Yoshida, K; Takano, S; Mukai, T; Iwamoto, T
      A dot-blot-immunoassay for semen identification using a polyclonal antibody against semenogelin, a powerful seminal marker

      FORENSIC SCIENCE INTERNATIONAL
    75. Clery, JM
      Stability of prostate specific antigen (PSA), and subsequent Y-STR typing,of Lucilia (Phaenicia) sericata (Meigen) (Diptera : Calliphoridae) maggotsreared from a simulated postmortem sexual assault

      FORENSIC SCIENCE INTERNATIONAL
    76. Kolotas, C; Zamboglou, N
      Role of interstitial brachytherapy in the treatment of malignant disease

      ONKOLOGIE
    77. Luboldt, HJ; Swoboda, A; Borgermann, C; Fornara, P; Rubben, H
      Clinical usefulness of free PSA in early detection of prostate cancer

      ONKOLOGIE
    78. Schuff-Werner, P; Zingler, C
      Possible value of positive PSA levels in malignant and nonmalignant breastdiseases

      ONKOLOGIE
    79. Yuksel, M; Cermik, TF; Kaya, M; Salan, A; Ustun, F; Salihoglu, YS; Yigitbasi, ON; Berkarda, S
      Extensive bone metastases in a patient with prostatic adenocarcinoma and normal serum prostate-specific antigen and prostatic acid phosphatase

      CLINICAL NUCLEAR MEDICINE
    80. Vicini, FA; Abner, A; Baglan, KL; Kestin, LL; Martinez, AA
      Defining a dose-response relationship with radiotherapy for prostate cancer: Is more really better?

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    81. Grimm, PD; Blasko, JC; Sylvester, JE; Meier, RM; Cavanagh, W
      10-year biochemical (prostate-specific antigen) control of prostate cancerwith I-125 brachytherapy

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    82. Taylor, JMG; Griffith, KA; Sandler, HM
      Definitions of biochemical failure in prostate cancer following radiation therapy

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    83. Do, T; Dave, G; Parker, R; Kagan, AR
      Serum PSA evaluations during salvage radiotherapy for post-prostatectomy biochemical failures as prognosticators for treatment outcomes

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    84. Hanlon, AL; Pinover, WH; Horwitz, EM; Hanks, GE
      Patterns and fate of PSA bouncing following 3D-CRT

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    85. Chuba, PJ; Moughan, J; Forman, JD; Owen, J; Hanks, G
      The 1989 patterns of care study for prostate cancer: Five-year outcomes

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    86. Perez, CA; Michalski, JM; Lockett, MA
      Chemical disease-free survival in localized carcinoma of prostate treated with external beam irradiation: Comparison of American Society of Therapeutic Radiology and Oncology Consensus or 1 ng/ml as endpoint

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    87. Horwitz, EM; Winter, K; Hanks, GE; Lawton, CA; Russell, AH; Machtay, M
      Subset analysis of RTOG 85-31 and 86-10 indicates an advantage for long-term vs. short-term adjuvant hormones for patients with locally advanced nonmetastatic prostate cancer treated with radiation therapy

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    88. Hodgson, DC; Catton, CN; Warde, P; Gospodarowicz, MK; Milosevic, MF; McLean, M; Catton, P
      The impact of irregularly rising prostate-specific antigen and "impending failure" on the apparent outcome of localized prostate cancer following radiotherapy

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    89. Lee, AK; Schultz, D; Renshaw, AA; Richie, JP; D'Amico, AV
      Optimizing patient selection for prostate monotherapy

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    90. D'Amico, AV; Schultz, D; Silver, B; Henry, L; Hurwitz, M; Kaplan, I; Beard, CJ; Renshaw, AA
      The clinical utility of the percent of positive prostate biopsies in predicting biochemical outcome following external-beam radiation therapy for patients with clinically localized prostate cancer

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    91. Sanchez-Nieto, B; Nahum, AE; Dearnaley, DP
      Individualization of dose prescription based on normal-tissue dose-volume and radiosensitivity data

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    92. Okada, T; Sato, Y; Kobayashi, N; Sumida, K; Satomura, S; Matsuura, S; Takasaki, M; Endo, T
      Structural characteristics of the N-glycans of two isoforms of prostate-specific antigens purified from human seminal fluid

      BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
    93. An, CD; Yoshiki, T; Lee, G; Okada, Y
      Evaluation of a rapid qualitative prostate specific antigen assay, the OneStep PSA (TM) test

      CANCER LETTERS
    94. Boccon-Gibod, L
      Rising PSA with a negative biopsy

      EUROPEAN UROLOGY
    95. Carroll, P
      Rising PSA after a radical treatment

      EUROPEAN UROLOGY
    96. Borboroglu, PG; Amling, CL
      Correlation of positive prostate sextant biopsy locations to sites of positive surgical margins in radical prostatectomy specimens

      EUROPEAN UROLOGY
    97. Karazanashvili, G; Managadze, L
      Prostate-specific antigen (PSA) value change after antibacterial therapy of prostate inflammation, as a diagnostic method for prostate cancer screening in cases of PSA value within 4-10 ng/ml and nonsuspicious results of digital rectal examination

      EUROPEAN UROLOGY
    98. Luboldt, HJ; Bex, A; Swoboda, A; Husing, J; Rubben, H
      Early detection of prostate cancer in Germany: A study using digital rectal examination and 4.0 ng/ml prostate-specific antigen as cutoff

      EUROPEAN UROLOGY
    99. Lein, M; Jung, K; Elgeti, U; Petras, T; Stephan, C; Brux, B; Sinha, P; Winkelmann, B; Schnorr, D; Loening, SA
      Comparison of the clinical validity of free prostate-specific antigen, alpha-1 antichymotrypsin-bound prostate-specific antigen and complexed prostate-specific antigen in prostate cancer diagnosis

      EUROPEAN UROLOGY
    100. Recchia, F; Sica, G; De Filippis, S; Rosselli, M; Pompili, PL; Rea, S
      Phase II study of epirubicin, mitomycin c, and 5-fluorouracil in hormone-refractory prostatic carcinoma

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/08/20 alle ore 12:50:32